Pharma

Your Article Summary

See Latest Articles

GVK Biosciences and Crelux set up Fragment-based Drug Discovery Platform to deliver Lead Molecules
b3c newswire, 03/04/09

GVK Biosciences and CRELUX announced that they have set-up a highly robust fragment-based drug discovery platform proven to deliver rapidly, viable lead molecules. CRELUX's high performance structural biology technologies together with GVK BIO's mature computer-assisted drug design tools and other components of its drug discovery and development engine, encompass all steps from challenging targets to novel drug candidates.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

Position statement of the Portuguese Society of Nephrology on the clinical use of biotechnological drugs in renal patients
Portuguese Journal of Nephrology and Hypertension, 10/12/09

Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09

See All of Biotechnology

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09

Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09

See All of Research & Development